NanoString Competitors and Similar CompaniesClear all
NanoString's competitors and similar companies include Personalis, EKF Diagnostics, Viapath and Varex Imaging.
 NanoString NS Wind Down (formerly NanoString Technologies) is a provider of life science tools for translational research and molecular diagnostics. |  EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate. |  Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. | |||
Founding Date | Founding Date 2003 | Founding Date 2011 | Founding Date 1990 | Founding Date 2009 | Founding Date 2017 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ Amsterdam, NL | Locations Fremont, US HQ West Wickham, GB | Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Salt Lake City, US HQ Wuxi, CN Walluf, DE Willich, DE Milano, IT Doetinchem, NL Calamba, PH see more |
Employees | Employees 7038% decrease | Employees 22344% decrease | Employees 303 | Employees 2701% decrease | Employees 2,4004% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) 157.5 m | Valuation ($) N/A | Valuation ($) 543.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $127.3m (FY, 2022) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) £51.6m (FY, 2025) | Revenue (est.) £122m (FY, 2018) | Revenue (est.) $844.6m (FY, 2025) |
Cost of goods | Cost of goods $65.5m (FY, 2022) | Cost of goods $53.9m (FY, 2025) | Cost of goods £19.7m (FY, 2025) | Cost of goods £88.9m (FY, 2018) | Cost of goods $554.1m (FY, 2025) |
Gross profit | Gross profit $61.8m (FY, 2022) | Gross profit $15.8m (FY, 2025) | Gross profit £32.1m (FY, 2025) | Gross profit £33.1m (FY, 2018) | Gross profit $290.5m (FY, 2025) |
Net income | Net income ($159.5m) (FY, 2022) | Net income ($81.3m) (FY, 2025) | Net income £2.5m (FY, 2025) | Net income £2.5m (FY, 2018) | Net income ($69.9m) (FY, 2025) |
Operating ⚠ | |||||
Patents (US) | Patents (US) 34 (Q2, 2022) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 275 (FY, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 152m | Total funding raised $ 75m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease
Personalis is a biotechnology company that specializes in cancer genomics.
View companyEKF Diagnostics
HQ
Penarth, GB
Employees
303
EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
View companyViapath
HQ
Bedford, GB
Employees
270↓ 1% decrease
Viapath provides pathology and testing its partners, and NHS and private sector organizations.
View company
Varex Imaging
HQ
Salt Lake City, US
Employees
2,400↑ 4% increase
Varex Imaging is a developer and manufacturer of X-ray imaging components.
View company